Merck Pays $650 Million To Settle Medicaid Pricing, Marketing Charges
This article was originally published in The Pink Sheet Daily
Executive Summary
Drug companies must respect Medicaid’s “best price” reporting, U.S. Attorney Meehan tells “The Pink Sheet” DAILY.